激动剂-话题@MedSci

#激动剂#

173篇内容 | 3326人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1627746, encodeId=83eb162e74671, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Oncotarget：从甘草和大豆提取的天然ERβ激动剂显著抑制卵巢癌细胞增殖！, objectType=article, longId=110763, objectId=c3c3110e631a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3c3110e631a, replyNumber=0, likeNumber=82, createdTime=2017-08-26, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3c3110e631a, moduleTitle=Oncotarget：从甘草和大豆提取的天然ERβ激动剂显著抑制卵巢癌细胞增殖！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3c3110e631a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627745, encodeId=e132162e745ab, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Lancet Gastroent Hepatol：Seladelpar，PPAR-δ选择性激动剂，对原发性胆管炎的治疗效果和安全性。, objectType=article, longId=108955, objectId=ab22108955ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab22108955ed, replyNumber=0, likeNumber=62, createdTime=2017-08-18, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab22108955ed, moduleTitle=Lancet Gastroent Hepatol：Seladelpar，PPAR-δ选择性激动剂，对原发性胆管炎的治疗效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab22108955ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627744, encodeId=ef41162e74419, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Hum Reprod Update：GnRH拮抗剂方案与激动剂长方案在IVF应用中的效果对比。, objectType=article, longId=107572, objectId=84ed10e572da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84ed10e572da, replyNumber=0, likeNumber=71, createdTime=2017-08-05, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84ed10e572da, moduleTitle=Hum Reprod Update：GnRH拮抗剂方案与激动剂长方案在IVF应用中的效果对比。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84ed10e572da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627743, encodeId=c684162e74354, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗2型糖尿病的依从性和持久性, objectType=article, longId=103787, objectId=d625103e8766, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d625103e8766, replyNumber=0, likeNumber=33, createdTime=2017-06-30, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d625103e8766, moduleTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗2型糖尿病的依从性和持久性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d625103e8766)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627742, encodeId=5227162e7426d, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Respir Med：COPD：β2激动剂和抗胆碱能药物的BDR不尽相同, objectType=article, longId=103149, objectId=6c13103149d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6c13103149d5, replyNumber=0, likeNumber=57, createdTime=2017-06-25, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6c13103149d5, moduleTitle=Respir Med：COPD：β2激动剂和抗胆碱能药物的BDR不尽相同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c13103149d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627741, encodeId=255d162e7417e, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Diabetes Obes Metab：哪种高血糖素样肽-1受体激动剂胃肠道更友好？, objectType=article, longId=99074, objectId=a576990e448, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a576990e448, replyNumber=0, likeNumber=67, createdTime=2017-05-20, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a576990e448, moduleTitle=Diabetes Obes Metab：哪种高血糖素样肽-1受体激动剂胃肠道更友好？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a576990e448)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627740, encodeId=deeb162e74078, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Stroke：脑卒中后Sonic Hedgehog信号通路激动剂治疗可以提高功能恢复！, objectType=article, longId=98433, objectId=91839843350, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91839843350, replyNumber=0, likeNumber=74, createdTime=2017-05-12, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91839843350, moduleTitle=Stroke：脑卒中后Sonic Hedgehog信号通路激动剂治疗可以提高功能恢复！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=91839843350)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627739, encodeId=ed10162e7397c, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Heart：伴有CVD高风险的COPD患者采用吸入性β2-受体激动剂和糖皮质激素治疗的心血管结局如何？, objectType=article, longId=96225, objectId=0b3f96225d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3f96225d3, replyNumber=0, likeNumber=72, createdTime=2017-04-20, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3f96225d3, moduleTitle=Heart：伴有CVD高风险的COPD患者采用吸入性β2-受体激动剂和糖皮质激素治疗的心血管结局如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3f96225d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627738, encodeId=f67c162e73887, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=KIDNEY INT：β2-肾上腺素能受体激动剂是巨噬细胞激活新的调节因子！, objectType=article, longId=95250, objectId=0f6a9525035, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f6a9525035, replyNumber=0, likeNumber=70, createdTime=2017-04-11, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f6a9525035, moduleTitle=KIDNEY INT：β2-肾上腺素能受体激动剂是巨噬细胞激活新的调节因子！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f6a9525035)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627737, encodeId=437c162e737e5, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=SCI REP：多巴胺D1受体激动剂可以抑制乳腺肿瘤及骨转移进展, objectType=article, longId=94778, objectId=363494e7878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=363494e7878, replyNumber=0, likeNumber=80, createdTime=2017-04-07, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=363494e7878, moduleTitle=SCI REP：多巴胺D1受体激动剂可以抑制乳腺肿瘤及骨转移进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=363494e7878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627736, encodeId=3f98162e73609, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Diabetes Care：胰岛素和胰高血糖素样肽1受体激动剂联合治疗2型糖尿病！, objectType=article, longId=93430, objectId=5ed393430f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ed393430f3, replyNumber=0, likeNumber=36, createdTime=2017-03-27, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ed393430f3, moduleTitle=Diabetes Care：胰岛素和胰高血糖素样肽1受体激动剂联合治疗2型糖尿病！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ed393430f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627735, encodeId=f8cf162e73561, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Diabetes Care：GLP-1受体激动剂dulaglutide治疗的胰腺安全评估分析！, objectType=article, longId=91502, objectId=711891502a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=711891502a5, replyNumber=0, likeNumber=101, createdTime=2017-03-13, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=711891502a5, moduleTitle=Diabetes Care：GLP-1受体激动剂dulaglutide治疗的胰腺安全评估分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=711891502a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627734, encodeId=8778162e734e8, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Crit Care Med：吸入的皮质类固醇和β激动剂对ARDS的作用, objectType=article, longId=90263, objectId=8589902631e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8589902631e, replyNumber=0, likeNumber=61, createdTime=2017-03-02, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8589902631e, moduleTitle=Crit Care Med：吸入的皮质类固醇和β激动剂对ARDS的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8589902631e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627733, encodeId=b2e6162e733dd, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=AIM：接受阿片类药物激动剂治疗的HCV患者使用elbasvir-grazoprevir治疗的SVR12较高, objectType=article, longId=74873, objectId=3233e487368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3233e487368, replyNumber=0, likeNumber=34, createdTime=2016-08-11, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3233e487368, moduleTitle=AIM：接受阿片类药物激动剂治疗的HCV患者使用elbasvir-grazoprevir治疗的SVR12较高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3233e487368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627732, encodeId=23d1162e732c4, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=NEJM：遗传性肥胖不用怕，黑皮素-4受体激动剂让你成功减肥, objectType=article, longId=74503, objectId=743fe4503cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=743fe4503cd, replyNumber=0, likeNumber=57, createdTime=2016-08-06, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=743fe4503cd, moduleTitle=NEJM：遗传性肥胖不用怕，黑皮素-4受体激动剂让你成功减肥, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=743fe4503cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627731, encodeId=3d31162e73166, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=胰高血糖素样肽-1受体激动剂研究进展, objectType=article, longId=73867, objectId=f2e1e386705, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2e1e386705, replyNumber=0, likeNumber=67, createdTime=2016-07-29, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2e1e386705, moduleTitle=胰高血糖素样肽-1受体激动剂研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2e1e386705)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627730, encodeId=66d3162e7309b, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Hum Reprod：GnRH拮抗剂vs.GnRH激动剂，哪种发生OHSS的风险更低呢？, objectType=article, longId=72337, objectId=1bf3e233786, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bf3e233786, replyNumber=0, likeNumber=64, createdTime=2016-07-09, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bf3e233786, moduleTitle=Hum Reprod：GnRH拮抗剂vs.GnRH激动剂，哪种发生OHSS的风险更低呢？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bf3e233786)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627729, encodeId=fdee162e7292d, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=JAMA Intern Med：使用大剂量胰岛素的2型糖尿病患者可以尝试加入GLP1受体激动剂, objectType=article, longId=70202, objectId=4320e0202fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4320e0202fa, replyNumber=0, likeNumber=31, createdTime=2016-06-09, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4320e0202fa, moduleTitle=JAMA Intern Med：使用大剂量胰岛素的2型糖尿病患者可以尝试加入GLP1受体激动剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4320e0202fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627728, encodeId=e00f162e72831, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Pediatrics：孕妇或许应谨慎使用β2-肾上腺素能受体激动剂, objectType=article, longId=62193, objectId=2bef62193bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bef62193bf, replyNumber=0, likeNumber=53, createdTime=2016-01-17, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bef62193bf, moduleTitle=Pediatrics：孕妇或许应谨慎使用β2-肾上腺素能受体激动剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bef62193bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1627727, encodeId=8b9f162e727db, content=<a href='/topic/show?id=ab4f66e8913' target=_blank style='color:#2F92EE;'>#激动剂#</a>, objectTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗糖尿病的有效性和安全性荟萃分析, objectType=article, longId=61856, objectId=db2c6185660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db2c6185660, replyNumber=0, likeNumber=27, createdTime=2016-01-09, rootId=0, userName=medscijoin, userId=95bc21134754, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db2c6185660, moduleTitle=Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗糖尿病的有效性和安全性荟萃分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db2c6185660)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

激动剂

2020-05-29

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Oncotarget：从甘草和大豆提取的天然ERβ激动剂显著抑制卵巢癌细胞增殖！

2017-08-26

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Lancet Gastroent Hepatol：Seladelpar，PPAR-δ选择性激动剂，对原发性胆管炎的治疗效果和安全性。

2017-08-18

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Hum Reprod Update：GnRH拮抗剂方案与激动剂长方案在IVF应用中的效果对比。

2017-08-05

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗2型糖尿病的依从性和持久性

2017-06-30

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Respir Med：COPD：β2激动剂和抗胆碱能药物的BDR不尽相同

2017-06-25

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Diabetes Obes Metab：哪种高血糖素样肽-1受体激动剂胃肠道更友好？

2017-05-20

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Stroke：脑卒中后Sonic Hedgehog信号通路激动剂治疗可以提高功能恢复！

2017-05-12

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Heart：伴有CVD高风险的COPD患者采用吸入性β2-受体激动剂和糖皮质激素治疗的心血管结局如何？

2017-04-20

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

KIDNEY INT：β2-肾上腺素能受体激动剂是巨噬细胞激活新的调节因子！

2017-04-11

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

SCI REP：多巴胺D1受体激动剂可以抑制乳腺肿瘤及骨转移进展

2017-04-07

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Diabetes Care：胰岛素和胰高血糖素样肽1受体激动剂联合治疗2型糖尿病！

2017-03-27

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Diabetes Care：GLP-1受体激动剂dulaglutide治疗的胰腺安全评估分析！

2017-03-13

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Crit Care Med：吸入的皮质类固醇和β激动剂对ARDS的作用

2017-03-02

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

AIM：接受阿片类药物激动剂治疗的HCV患者使用elbasvir-grazoprevir治疗的SVR12较高

2016-08-11

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

NEJM：遗传性肥胖不用怕，黑皮素-4受体激动剂让你成功减肥

2016-08-06

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

胰高血糖素样肽-1受体激动剂研究进展

2016-07-29

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Hum Reprod：GnRH拮抗剂vs.GnRH激动剂，哪种发生OHSS的风险更低呢？

2016-07-09

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

JAMA Intern Med：使用大剂量胰岛素的2型糖尿病患者可以尝试加入GLP1受体激动剂

2016-06-09

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Pediatrics：孕妇或许应谨慎使用β2-肾上腺素能受体激动剂

2016-01-17

medscijoin (审核中...)

前往app查看评论内容

#激动剂#

Diabetes Obes Metab：胰高血糖素样肽-1受体激动剂治疗糖尿病的有效性和安全性荟萃分析

2016-01-09

科室
- - 订阅+
  - 更多科室
工具
服务